IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,662 | +88.1% | 585 | +191.0% | 0.00% | – |
| Q2 2023 | $1,415 | -1.9% | 201 | -14.8% | 0.00% | – |
| Q1 2023 | $1,442 | +2.6% | 236 | +7.3% | 0.00% | – |
| Q4 2022 | $1,406 | -71.9% | 220 | -59.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 536 | +5.1% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 510 | +97.7% | 0.00% | – |
| Q1 2022 | $4,000 | -66.7% | 258 | -60.5% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 653 | -5.4% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | +88.9% | 690 | +93.8% | 0.00% | – |
| Q2 2021 | $9,000 | +200.0% | 356 | +350.6% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 79 | +75.6% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 45 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |